Topics

"Akebia Therapeutics Participate Upcoming Investor Conferences" Drugs and Medication Database

02:09 EDT 16th September 2019 | BioPortfolio

Here are the most relevant "Akebia Therapeutics Participate Upcoming Investor Conferences" Drugs and Medications that we have found in our database.

More Information about "Akebia Therapeutics Participate Upcoming Investor Conferences" on BioPortfolio

We have published hundreds of Akebia Therapeutics Participate Upcoming Investor Conferences news stories on BioPortfolio along with dozens of Akebia Therapeutics Participate Upcoming Investor Conferences Clinical Trials and PubMed Articles about Akebia Therapeutics Participate Upcoming Investor Conferences for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Akebia Therapeutics Participate Upcoming Investor Conferences Companies in our database. You can also find out about relevant Akebia Therapeutics Participate Upcoming Investor Conferences Drugs and Medications on this site too.

Showing "Akebia Therapeutics Participate Upcoming Investor Conferences" Drugs and Medications 1–25 of 41

Probably Relevant

Kynamro [kastle therapeutics, llc]

NA

Possibly Relevant

Olopatadine hydrochloride [somerset therapeutics, llc]

OLOPATADINE Hydrochloride Ophthalmic Solution USP, 0.1%Somerset Therapeutics, LLC

Oxygen [breathe easy therapeutics, inc]

NA

Creon [atlantic biologicals corps]

These highlights do not include all the information needed to use CREON safely and effectively. See full prescribing information for CREON. CREON (pancrelipase) delayed-release capsules for oral use Initial U.S. Approval: 2009

Creon [atlantic biologicals corps]

These highlights do not include all the information needed to use CREON safely and effectively. See full prescribing information for CREON. CREON (pancrelipase) delayed-release capsules for oral use Initial U.S. Approval: 2009

Creon [atlantic biologicals corps]

These highlights do not include all the information needed to use CREON safely and effectively. See full prescribing information for CREON. CREON (pancrelipase) delayed-release capsules for oral use Initial U.S. Approval: 2009

Creon [physicians total care, inc.]

These highlights do not include all the information needed to use CREON safely and effectively. See full prescribing information for CREON.CREON (pancrelipase) delayed-release capsules for oral useInitial U.S. Approval: 2009

Creon [abbvie inc.]

These highlights do not include all the information needed to use CREON safely and effectively. See full prescribing information for CREON.CREON (pancrelipase) delayed-release capsules for oral useInitial U.S. Approval: 2009

Pertzye [digestive care, inc.]

These highlights do not include all the information needed to use PERTZYE safely and effectively. See full prescribing information for PERTZYE. PERTZYE (pancrelipase) delayed-release capsules, for oral use Initial U.S. Approval: 2012

Diclofenac sodium delayed release [cambridge therapeutics technologies, llc]

Diclofenac Sodium

Olopatadine hydrochloride [a-s medication solutions]

OLOPATADINE Hydrochloride Ophthalmic Solution USP, 0.1%Somerset Therapeutics, LLC

Sentradine [physician therapeutics llc]

Sentradine

Folotyn [allos therapeutics]

These highlights do not include all the information needed to use FOLOTYN safely and effectively. See full prescribing information for FOLOTYN.FOLOTYN (pralatrexate injection), for intravenous use Initial U.S. Approval: 2009

Pancreaze [janssen pharmaceuticals, inc.]

These highlights do not include all the information needed to use PANCREAZE safely and effectively. See full prescribing information for PANCREAZE. PANCREAZE (pancrelipase) delayed-release capsules Initial U.S. Approval – 2010

Pancreaze [vivus, inc.]

These highlights do not include all the information needed to use PANCREAZE safely and effectively. See full prescribing information for PANCREAZE . PANCREAZE (pancrelipase) delayed-release capsules Initial U.S. Approval – 2010

Zenpep [allergan, inc.]

These highlights do not include all the information needed to use ZENPEP safely and effectively. See full prescribing information for ZENPEP.     ZENPEP (pancrelipase) delayed release capsules Initial U.S. Approval:   2009

Urised [key therapeutics]

Urised

Towerx effervescent potassium [tower laboratories ltd]

NA

K-effervescent [qualitest pharmaceuticals]

NA

Tobramycin [somerset therapeutics, llc]

Rx OnlyFor Topical Ophthalmic Use Only

Multi-vitamin fluoride drops [h.j. harkins company, inc.]

Unknown Title

Diclofenac sodium [cambridge therapeutics technologies, llc]

Diclofenac Sodium Delayed-release Tablets, USP

Tri-vite drops with fluoride [method pharmaceuticals, llc]

Tri-Vite Drops with Fluroide 0_5 mg

Tri-vite drops with fluoride [method pharmaceuticals, llc]

Tri-Vite Drops with Fluroide 0_25 mg

Viokace [allergan, inc.]

These highlights do not include all the information needed to use VIOKACE safely and effectively. See full prescribing information for VIOKACE VIOKACE(pancrelipase) tablets, for oral useInitial U.S. Approval: 2012



Quick Search